Feb 24, 2025

Featuring slide presentations and related discussion from Prof Martin Hutchings, Dr Manali Kamdar, Dr Matthew Lunning and Prof Gilles Salles, including the following topics:

• Evolving Role of Chimeric Antigen Receptor (CAR) T-Cell Therapy in Diffuse Large B-Cell Lymphoma (DLBCL) — Dr Kamdar (0:00)
• Case: A 61-year-old...

Feb 21, 2025

Featuring perspectives from Dr Arvind Dasari, Dr Christopher Lieu, Dr Van K Morris, Dr Jenny Seligmann and Prof Eric Van Cutsem, moderated by Dr Lieu, including the following topics:

• Introduction (0:00)
• Optimizing Biomarker Assessment for Patients with Colorectal Cancer (CRC) — Dr Dasari (2:18)
• Identification and...

Feb 19, 2025

Featuring an interview with Dr Surbhi Sidana, including the following topics:

• Long-term outcomes for patients with relapsed/refractory multiple myeloma (MM) (0:00)
• Clinical considerations in the selection of patients for chimeric antigen receptor (CAR) T-cell therapy (3:34)
• Practical challenges for patients receiving...

Feb 18, 2025

Featuring a slide presentation and related discussion from Dr Surbhi Sidana, including the following topics:

• Key clinical data of FDA-approved chimeric antigen receptor (CAR) T-cell therapies (0:00)
• Real-world evidence evaluating utility of CAR T-cell therapies in the clinic (8:08)
• Impact of prior BCMA-targeted...

Feb 14, 2025

Featuring slide presentations and related discussion from Dr Joyce O'Shaughnessy, Dr Mark Pegram and Prof Peter Schmid, including the following topics:

• Strategies to Identify Patients with HER2-Low and HER2-Ultralow Breast Cancer (0:00)
• Case: A woman in her mid 50s initially presenting with ER-positive, HER2 IHC...